Nathan Treybeck
Stock Analyst at Wells Fargo
(1.38)
# 3,477
Out of 5,182 analysts
27
Total ratings
29.41%
Success rate
-1.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $51 → $34 | $24.09 | +41.14% | 10 | Feb 26, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $87 → $94 | $114.52 | -17.92% | 3 | Feb 26, 2026 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $225 → $200 | $125.96 | +58.78% | 7 | Feb 20, 2026 | |
| ITGR Integer Holdings | Maintains: Equal-Weight | $72 → $84 | $85.35 | -1.58% | 5 | Feb 20, 2026 | |
| RMD ResMed | Maintains: Equal-Weight | $265 → $270 | $222.02 | +21.61% | 2 | Jan 30, 2026 |
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Overweight
Price Target: $51 → $34
Current: $24.09
Upside: +41.14%
LeMaitre Vascular
Feb 26, 2026
Maintains: Equal-Weight
Price Target: $87 → $94
Current: $114.52
Upside: -17.92%
iRhythm Holdings
Feb 20, 2026
Maintains: Overweight
Price Target: $225 → $200
Current: $125.96
Upside: +58.78%
Integer Holdings
Feb 20, 2026
Maintains: Equal-Weight
Price Target: $72 → $84
Current: $85.35
Upside: -1.58%
ResMed
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $265 → $270
Current: $222.02
Upside: +21.61%